We are live on ! Find out more
JCM

Jacobi Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 26.26%
This Fund
S&P 500
This Quarter Est. Return
+1.42%
1 Year Est. Return
+26.26%
3 Year Est. Return
+76.57%
5 Year Est. Return
+89.08%
10 Year Est. Return
+253.33%
AUM
$505M
AUM Growth
+$13.2M
Cap. Flow
+$11.2M
Cap. Flow %
2.21%
Top 10 Hldgs %
36.68%
Holding
1,113
New
27
Increased
309
Reduced
160
Closed
22

Top Buys

Rank Stock Value
1
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$26.3M
2
BND icon
Vanguard Total Bond Market
BND
+$13M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$6.22M
4
EW icon
Edwards Lifesciences
EW
+$4.16M
5
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$2.83M

Top Sells

Rank Stock Value
1
VOE icon
Vanguard Morningstar Mid-Cap Value ETF
VOE
+$25.5M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$14M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$5.64M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$2.08M
5
CELG
Celgene Corp
CELG
+$692K

Sector Composition

Rank Sector Weight
1 Financials 10.88%
2 Healthcare 8.11%
3 Technology 6.88%
4 Industrials 6.17%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEXEA
1101
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
– –
-4
Closed –
HTZ.RT
1102
DELISTED
Hertz Global Holdings
HTZ.RT
– –
-200
Closed –
GM.WS.B
1103
DELISTED
General Motors Company
GM.WS.B
– –
-24
Closed –
LLL
1104
DELISTED
L3 Technologies, Inc.
LLL
– –
-35
Closed -$9K
NVIV
1105
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
– –
0
– –
CRC
1106
DELISTED
California Resources Corporation
CRC
$0 ﹤0.01%
22
-2
-8% -$26
CPAH
1107
DELISTED
Counterpath Corp
CPAH
$0 ﹤0.01%
20
– –
ESV
1108
DELISTED
Ensco Rowan plc
ESV
– –
-50
Closed –
VVUS
1109
DELISTED
Vivus Inc
VVUS
$0 ﹤0.01%
24
– –
SPHS
1110
DELISTED
Sophiris Bio, Inc.
SPHS
$0 ﹤0.01%
400
– –
IBDK
1111
DELISTED
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
– –
-4,126
Closed -$103K
RHT
1112
DELISTED
Red Hat Inc
RHT
– –
-38
Closed -$7K
AIM
1113
AIM ImmunoTech
AIM
$7.03M
– –
0
– –
41 42 43 44
45

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return

Jacobi Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Jacobi Capital Management held 1,113 positions worth $505M, up 2.7% from $492M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.4%. Jacobi Capital Management opened 27 new positions and exited 22, leaving the 1,113-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Technology.

  • Jacobi Capital Management's largest Q3 2019 buy was Zscaler: 2,570 shares worth $121K.
  • Jacobi Capital Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2019, an estimated $26.3M increase.
  • Jacobi Capital Management's biggest Q3 2019 reduction was Vanguard Morningstar Mid-Cap Value ETF, cutting an estimated $25.5M.
  • Jacobi Capital Management fully exited AmeriGas Partners, L.P. in Q3 2019, selling an estimated $115K.
  • Jacobi Capital Management's ten largest holdings make up 37% of its $505M portfolio in Q3 2019.
  • Jacobi Capital Management opened 27 new positions and closed 22 in Q3 2019.
  • Jacobi Capital Management's portfolio value rose 2.7% quarter-over-quarter to $505M.

Based on Jacobi Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.